Coriolis Pharma

CDMO

Germany

https://www.coriolis-pharma.com/why-coriolis/meet-the-team/

Is this your company? Claim this profile

Drug Product

Advanced Modalities

Analytical & Bioanalytical Services

Regulatory, Tech Transfer & Support Services

Company Overview

About

Coriolis Pharma is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Formulation Development, Process Development, Scale-up

Therapeutic Areas

Infectious Disease

Quick Facts

HQ:Germany

Founded:2012

Employees:1,268

Capabilities & Services

Core Capabilities

Small Molecule API
Small Molecule Drug Product
Oral Solid Dose

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Oral Solid Dose

Containment Capabilities

Cytotoxic / ADC Handling

Production Scales

Pilot Scale

Phase I Clinical Trials

Clinical

Markets Served

North America

Regulatory Approvals

Drug Approval ESJJZF

EMA · #APR-T4URWU5Q · 2022-05-01

Drug Approval E55NK0

EMA · #APR-GVF8RMWQ · 2018-08-01

Certifications

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-6EEF8OKU

Issued: 2020-01-06

Expires: 2025-01-15

WHO GMP

World Health Organization

Cert #: CERT-UHW51WIV

Issued: 2020-03-22

Expires: 2025-07-13

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about Coriolis Pharma

Coriolis Pharma is headquartered in Germany.
Coriolis Pharma was founded in 2012.
Coriolis Pharma has 1,268 employees.
Coriolis Pharma's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.

Find CDMOs like Coriolis Pharma

Directory pages this company appears in, each with the full list of matching manufacturers.

CDMOs in Germany CDMOs in Europe Small Molecule API CDMOs Small Molecule Drug Product CDMOs Oral Solid Dose CDMOs Oral Solid Dose CDMOs Cytotoxic / ADC Handling CDMOs